Fortrea Holdings Inc. (FTRE)
USD 6.33
(-6.77%)
USD 6.33
(-6.77%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.35 Billion USD | 1.62% |
| 2022 | 4.28 Billion USD | -1.85% |
| 2021 | 4.36 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 3.56 Billion USD | -15.91% |
| 2024 Q1 | 4.24 Billion USD | -2.69% |
| 2023 Q4 | 4.35 Billion USD | 0.94% |
| 2023 Q3 | 4.31 Billion USD | -0.91% |
| 2023 Q1 | 4.3 Billion USD | 0.43% |
| 2023 Q2 | 4.35 Billion USD | 1.15% |
| 2023 FY | 4.35 Billion USD | 1.62% |
| 2022 Q4 | 4.28 Billion USD | 0.0% |
| 2022 FY | 4.28 Billion USD | -1.85% |
| 2021 FY | 4.36 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | -192.804% |
| Alkermes plc | 2.13 Billion USD | -103.967% |
| Agenus Inc. | 313.91 Million USD | -1288.028% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | -13.769% |
| Aptorum Group Limited | 20.64 Million USD | -21010.372% |
| Ardelyx, Inc. | 297.57 Million USD | -1364.216% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -469.158% |
| Bicycle Therapeutics plc | 595.34 Million USD | -631.879% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -5811.916% |
| ChromaDex Corporation | 54.96 Million USD | -7827.371% |
| Chimerix, Inc. | 212.77 Million USD | -1947.807% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -15311.501% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -888.099% |
| CRISPR Therapeutics AG | 2.22 Billion USD | -95.428% |
| Precision BioSciences, Inc. | 159.78 Million USD | -2626.983% |
| Dyadic International, Inc. | 8.21 Million USD | -52912.226% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -13627.788% |
| Fortress Biotech, Inc. | 167.52 Million USD | -2500.91% |
| Lantern Pharma Inc. | 43.64 Million USD | -9882.676% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -2600.682% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -29935.886% |
| Incyte Corporation | 6.78 Billion USD | 35.754% |
| IO Biotech, Inc. | 150.71 Million USD | -2790.962% |
| Jaguar Health, Inc. | 50.76 Million USD | -8483.417% |
| Novavax, Inc. | 1.85 Billion USD | -134.846% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -1045.405% |
| Opthea Limited | 188.79 Million USD | -2207.946% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -423.033% |
| ContextLogic Inc. | 423 Million USD | -930.071% |
| MiMedx Group, Inc. | 239.04 Million USD | -1722.738% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -2408.087% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -84183.404% |
| NextCure, Inc. | 129.41 Million USD | -3266.765% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -7976.666% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -11763.105% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -13389.366% |
| Vaxcyte, Inc. | 1.4 Billion USD | -209.478% |
| PDS Biotechnology Corporation | 59.39 Million USD | -7236.579% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -580.231% |
| Pharming Group N.V. | 462.85 Million USD | -841.377% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -11164.736% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -593.209% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -22925.126% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -22925.126% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -2535.616% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -9521.304% |
| Acelyrin, Inc. | 742.69 Million USD | -486.678% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -66053.265% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -67949.352% |
| Summit Therapeutics Inc. | 202.94 Million USD | -2046.943% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -5758.499% |
| Senti Biosciences, Inc. | 119.48 Million USD | -3546.681% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -1808.19% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -2490.888% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -52631.453% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -91173.811% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -828.66% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -3423.732% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -1484.73% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -821.496% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -43019.248% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -1931.272% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -384757.604% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -952.866% |
| Immix Biopharma, Inc. | 19.92 Million USD | -21767.829% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -1077.542% |
| MEI Pharma, Inc. | 41.37 Million USD | -10430.997% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -13345.658% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -1178.529% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -3616.955% |
| Fortress Biotech, Inc. | 167.52 Million USD | -2500.91% |
| Precigen, Inc. | 151.04 Million USD | -2784.741% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -12708.513% |
| AlloVir, Inc. | 190.79 Million USD | -2183.696% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -1057.441% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -760.738% |
| ImmuCell Corporation | 43.8 Million USD | -9846.105% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -571.045% |
| Onconetix, Inc. | 88.82 Million USD | -4805.572% |
| PureTech Health plc | 693.97 Million USD | -527.863% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -4360.46% |
| Elevation Oncology, Inc. | 89.09 Million USD | -4790.73% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -70154.757% |
| Seer, Inc. | 436.26 Million USD | -898.742% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -5239.902% |
| Innoviva, Inc. | 1.24 Billion USD | -250.396% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -3190.365% |
| ESSA Pharma Inc. | 149.12 Million USD | -2821.9% |
| GlycoMimetics, Inc. | 45.31 Million USD | -9515.046% |
| GT Biopharma, Inc. | 14.1 Million USD | -30782.415% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -1315.167% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -1702.708% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -823.318% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -8494.591% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -4476.314% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -689780.112% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -669.36% |
| Aptose Biosciences Inc. | 12.92 Million USD | -33617.819% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -19603.102% |
| Soligenix, Inc. | 9.79 Million USD | -44373.359% |
| Century Therapeutics, Inc. | 360.69 Million USD | -1108.015% |
| Kura Oncology, Inc. | 448.93 Million USD | -870.564% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -1501.035% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -25093.408% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -3828.544% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -2023.899% |
| Autolus Therapeutics plc | 375.38 Million USD | -1060.741% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -1631.549% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -1126.744% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -8768.355% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -559.049% |
| GRI Bio, Inc. | 2.95 Million USD | -147301.894% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -40985.404% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -2455.318% |
| IGM Biosciences, Inc. | 423.41 Million USD | -929.071% |
| INmune Bio, Inc. | 57 Million USD | -7544.076% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -1858.239% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -5090.773% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -16583.477% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -63201.999% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -5692.146% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -2858.888% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -2532.686% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -592.054% |
| Verastem, Inc. | 149.71 Million USD | -2810.271% |
| Abeona Therapeutics Inc. | 64 Million USD | -6707.912% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -750.76% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -2720.979% |
| Histogen Inc. | 19.07 Million USD | -22744.859% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -19136.938% |
| Surrozen, Inc. | 46.08 Million USD | -9355.729% |
| Organovo Holdings, Inc. | 6.34 Million USD | -68528.13% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -101027.507% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -2925.271% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -36819.166% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -5688.914% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -51045.347% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -1100.433% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -23980.382% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -914.713% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -34448.816% |
| Apollomics, Inc. | 55.38 Million USD | -7766.828% |
| Amarin Corporation plc | 831.68 Million USD | -423.901% |
| Mesoblast Limited | 669.15 Million USD | -551.152% |
| Turnstone Biologics Corp. | 112.81 Million USD | -3762.252% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -656.775% |
| Synaptogenix, Inc. | 31.11 Million USD | -13904.135% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -35661.655% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -695.02% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -74099.699% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -59220.704% |
| Exelixis, Inc. | 2.94 Billion USD | -48.085% |
| Better Therapeutics, Inc. | 22.94 Million USD | -18891.414% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -1095.263% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -452.432% |
| NLS Pharmaceutics AG | 1.84 Million USD | -235852.738% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -54510.852% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -29550.902% |
| Gritstone bio, Inc. | 177.76 Million USD | -2351.046% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -4468.253% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -24293.316% |
| Avid Bioservices, Inc. | 336.55 Million USD | -1194.64% |
| Insmed Incorporated | 1.32 Billion USD | -227.649% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -45153.883% |
| MediWound Ltd. | 66.45 Million USD | -6456.223% |
| OmniAb, Inc. | 401.98 Million USD | -983.921% |
| Alector, Inc. | 621.82 Million USD | -600.709% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -1115.059% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -80918.966% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -7585.74% |
| Zai Lab Limited | 1.03 Billion USD | -320.459% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -810.683% |
| Aura Biosciences, Inc. | 255.07 Million USD | -1608.203% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -480.938% |
| Immunic, Inc. | 54.29 Million USD | -7924.457% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -1536.667% |
| Veracyte, Inc. | 1.13 Billion USD | -282.942% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -36754.27% |
| FibroGen, Inc. | 423.52 Million USD | -928.784% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -123930.743% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -91889.938% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -80150.809% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 61.757% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -49385.52% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -742.046% |
| TG Therapeutics, Inc. | 329.58 Million USD | -1222.018% |
| Galecto, Inc. | 38.22 Million USD | -11298.226% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -15094.588% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -1750.946% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -17439.651% |
| XBiotech Inc. | 227.24 Million USD | -1817.419% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -4468.253% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -2955.54% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -1423.944% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -3307.55% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -1040.631% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -192.231% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -1094.27% |
| Vaxxinity, Inc. | 44.35 Million USD | -9723.913% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -742.851% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -23314.06% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -1328.356% |
| NexImmune, Inc. | 8.59 Million USD | -50600.79% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -40563.768% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -25339.952% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 86.828% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -19570.327% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -1110679.702% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -2413.832% |
| Ainos, Inc. | 31.84 Million USD | -13583.898% |
| Pluri Inc. | 39.52 Million USD | -10923.351% |
| Prothena Corporation plc | 696.38 Million USD | -525.691% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -1441.739% |
| Celularity Inc. | 143.88 Million USD | -2928.168% |
| Rallybio Corporation | 115.62 Million USD | -3668.552% |
| Cue Biopharma, Inc. | 61.53 Million USD | -6981.424% |
| MeiraGTx Holdings plc | 458.16 Million USD | -851.005% |
| Omeros Corporation | 378.26 Million USD | -1051.879% |
| Humacyte, Inc. | 128.22 Million USD | -3298.142% |
| Immunocore Holdings plc | 597 Million USD | -629.848% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -13839.026% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -6258.091% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -315.268% |
| CalciMedica, Inc. | 12.18 Million USD | -35658.72% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -1617.8% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -2449.442% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -1300.871% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -670.778% |
| Pulmatrix, Inc. | 33.95 Million USD | -12731.144% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -15950.984% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -2993.328% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -234.918% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -3246.826% |
| Cytokinetics, Incorporated | 824.31 Million USD | -428.584% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -20527.752% |
| Nutriband Inc. | 7.51 Million USD | -57863.426% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -5418.656% |
| Vor Biopharma Inc. | 209.82 Million USD | -1976.558% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 39.672% |
| Evogene Ltd. | 51.1 Million USD | -8426.643% |
| ProKidney Corp. | 420.55 Million USD | -936.067% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -7846.31% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -45667.571% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -697.467% |
| CorMedix Inc. | 82.05 Million USD | -5209.776% |
| BioLineRx Ltd. | 63.92 Million USD | -6716.113% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -982.354% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -15351.064% |
| Atai Life Sciences N.V. | 293.47 Million USD | -1384.677% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -2571.008% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -3319.611% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -675.265% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -4405.009% |
| MediciNova, Inc. | 66.26 Million USD | -6474.923% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -4854.291% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -97543.29% |
| GeoVax Labs, Inc. | 9.28 Million USD | -46836.305% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -640.723% |
| Biomea Fusion, Inc. | 199.92 Million USD | -2079.395% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | -128.943% |
| Mereo BioPharma Group plc | 66.49 Million USD | -6452.279% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -798.214% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -610.939% |
| Absci Corporation | 234.48 Million USD | -1758.24% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -59465.277% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -1181.94% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -2539.416% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -727.858% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -1469.071% |
| Allakos Inc. | 243.61 Million USD | -1688.597% |
| Imunon, Inc. | 21.91 Million USD | -19779.488% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -1590.843% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -601.059% |
| BioAtla, Inc. | 119.65 Million USD | -3541.378% |
| NLS Pharmaceutics AG | 1.84 Million USD | -235852.738% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -135216.77% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -577.808% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -4441.825% |
| XOMA Corporation | 234.3 Million USD | -1759.659% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -1869.489% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -3362.382% |
| aTyr Pharma, Inc. | 122.06 Million USD | -3469.515% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -2731.134% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -650.891% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -788.456% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -3844.274% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -28646.053% |
| Akari Therapeutics, Plc | 4.35 Million USD | -99950.517% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -25474.425% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -151.386% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -141184.688% |
| UroGen Pharma Ltd. | 178.31 Million USD | -2343.596% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -825.614% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -783970.972% |
| Orgenesis Inc. | 14.55 Million USD | -29842.276% |
| Entera Bio Ltd. | 11.76 Million USD | -36935.274% |
| GH Research PLC | 226.3 Million USD | -1825.409% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -7866.505% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -3955.624% |
| Xencor, Inc. | 952.69 Million USD | -357.357% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -55878.009% |
| Replimune Group, Inc. | 487.72 Million USD | -793.378% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -53885.28% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -571.951% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -141184.688% |
| Portage Biotech Inc. | 7.77 Million USD | -55912.341% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -97543.29% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -1473.309% |
| OncoCyte Corporation | 74.89 Million USD | -5717.978% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -214197.518% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -75197.543% |
| Purple Biotech Ltd. | 44.3 Million USD | -9735.222% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -12667.977% |
| scPharmaceuticals Inc. | 94.47 Million USD | -4511.818% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -24046.357% |
| HilleVax, Inc. | 344.43 Million USD | -1165.032% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -137091.436% |
| Tharimmune, Inc. | 10.94 Million USD | -39704.893% |
| Genprex, Inc. | 10.67 Million USD | -40733.723% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -778.123% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -4426.867% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -179504.287% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -104503.57% |
| OKYO Pharma Limited | 1.54 Million USD | -282603.028% |
| Savara Inc. | 177.56 Million USD | -2353.876% |
| Curis, Inc. | 77.28 Million USD | -5538.053% |
| Daré Bioscience, Inc. | 21.28 Million USD | -20373.433% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -6713.576% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -53785.728% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -22393.418% |
| BeiGene, Ltd. | 5.8 Billion USD | 24.944% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -35705.736% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | -108.619% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -1117.262% |
| Erasca, Inc. | 395.29 Million USD | -1002.26% |
| bluebird bio, Inc. | 619.16 Million USD | -603.726% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -100682.515% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 36.313% |
| DBV Technologies S.A. | 182.98 Million USD | -2281.166% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -100682.515% |
| Moderna, Inc. | 18.42 Billion USD | 76.353% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -23818.318% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -37507.457% |
| Molecular Templates, Inc. | 35.38 Million USD | -12214.388% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -3051.34% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -452.304% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -1334.446% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -4091.792% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -835.77% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -1290.136% |
| MacroGenics, Inc. | 306.82 Million USD | -1320.116% |
| RenovoRx, Inc. | 1.46 Million USD | -297116.917% |
| Adicet Bio, Inc. | 207.29 Million USD | -2001.932% |
| Prime Medicine, Inc. | 193.85 Million USD | -2147.706% |
| Aditxt, Inc. | 44.57 Million USD | -9674.256% |
| Adagene Inc. | 115.72 Million USD | -3665.008% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -97722.522% |
| Quantum-Si incorporated | 298.25 Million USD | -1360.922% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -192.931% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -56420.048% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -1140.375% |
| SciSparc Ltd. | 11.18 Million USD | -38866.196% |
| Vericel Corporation | 353.65 Million USD | -1132.041% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -35577.88% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -7557.563% |
| Generation Bio Co. | 374.75 Million USD | -1062.67% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -1610.947% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -2647.861% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -1176.405% |
| Invivyd, Inc. | 229.18 Million USD | -1801.205% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -416.268% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -35704.85% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -2288.947% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -21233.725% |
| 2seventy bio, Inc. | 565.42 Million USD | -670.605% |
| ADMA Biologics, Inc. | 329.18 Million USD | -1223.645% |
| Clene Inc. | 52.34 Million USD | -8224.64% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -7318.49% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -3254.427% |
| GeoVax Labs, Inc. | 9.28 Million USD | -46836.305% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -566.545% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -4105.339% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -3241.77% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -4366.539% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -6037.161% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -1696.391% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | -122.296% |
| Evaxion Biotech A/S | 12.88 Million USD | -33706.57% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -1628.636% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -478.885% |
| Trevena, Inc. | 40.6 Million USD | -10630.698% |
| Surrozen, Inc. | 46.08 Million USD | -9355.729% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -1829.185% |
| Cingulate Inc. | 3.49 Million USD | -124696.788% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -26102.417% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -6532.973% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -37190.022% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -1522.691% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -481.77% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -3361.062% |
| Clearmind Medicine Inc. | 4.32 Million USD | -100658.743% |
| Kronos Bio, Inc. | 213.27 Million USD | -1942.958% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -2626.931% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -50798.242% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -1082.447% |
| Statera Biopharma, Inc. | 21.16 Million USD | -20482.262% |
| ImmunityBio, Inc. | 504.45 Million USD | -763.749% |
| Korro Bio, Inc. | 221.66 Million USD | -1865.687% |
| Kineta, Inc. | 10.28 Million USD | -42281.091% |
| BioVie Inc. | 25.2 Million USD | -17184.752% |
| Codexis, Inc. | 136.56 Million USD | -3090.662% |
| Celularity Inc. | 143.88 Million USD | -2928.168% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -585.792% |
| Celcuity Inc. | 191.21 Million USD | -2178.639% |
| Virax Biolabs Group Limited | 5.48 Million USD | -79353.403% |
| Cibus, Inc. | 544.41 Million USD | -700.351% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -3361.007% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -21109.112% |
| IN8bio, Inc. | 33.7 Million USD | -12825.925% |
| Kodiak Sciences Inc. | 479.37 Million USD | -808.939% |
| Annexon, Inc. | 297.67 Million USD | -1363.749% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -2418.467% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -3069.587% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -20655.49% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | -45.722% |
| Eyenovia, Inc. | 28.77 Million USD | -15040.01% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -1790.096% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -60215.615% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -7051.627% |
| Arcellx, Inc. | 825.13 Million USD | -428.061% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -5237.286% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -842.556% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -14069.756% |
| Moolec Science SA | 24.05 Million USD | -18016.285% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -1304.982% |
| Geron Corporation | 394.07 Million USD | -1005.675% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -4183.945% |
| Royalty Pharma plc | 16.38 Billion USD | 73.402% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -632.342% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -62191.855% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -36127.534% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -1827.453% |
| Humacyte, Inc. | 128.22 Million USD | -3298.142% |
| Structure Therapeutics Inc. | 482.01 Million USD | -803.951% |
| 89bio, Inc. | 596.26 Million USD | -630.744% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -1628.005% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -235424.324% |
| Genelux Corporation | 27.89 Million USD | -15521.124% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -4773.662% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -1799.15% |
| Notable Labs, Ltd. | 19.54 Million USD | -22197.733% |
| Liquidia Corporation | 120.43 Million USD | -3518.005% |
| Mustang Bio, Inc. | 17.74 Million USD | -24458.674% |
| Immunovant, Inc. | 666.71 Million USD | -553.536% |
| Quantum-Si incorporated | 298.25 Million USD | -1360.922% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -2917.431% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -7945.052% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -2382.084% |
| Acasti Pharma Inc. | 73.3 Million USD | -5844.338% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -95614.654% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -16583.477% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -351.618% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -83855.084% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -19026.465% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -8343.695% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -2311.41% |
| PepGen Inc. | 143.05 Million USD | -2945.885% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -11301.209% |
| United Therapeutics Corporation | 7.16 Billion USD | 39.205% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -22611.493% |
| Solid Biosciences Inc. | 164.93 Million USD | -2541.704% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -74099.699% |
| Immuneering Corporation | 102.58 Million USD | -4147.424% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -101027.507% |
| Silo Pharma, Inc. | 7.74 Million USD | -56149.944% |
| Belite Bio, Inc | 94.64 Million USD | -4503.876% |
| XOMA Corporation | 234.3 Million USD | -1759.659% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -1768.535% |
| Bionomics Limited | 27.64 Million USD | -15658.926% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -985.49% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -3957.437% |
| uniQure N.V. | 831.68 Million USD | -423.898% |
| Cassava Sciences, Inc. | 151.66 Million USD | -2772.949% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -97722.522% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -1490.887% |
| Forte Biosciences, Inc. | 38.98 Million USD | -11078.04% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -106874.664% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -11730.252% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -60215.615% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -123930.743% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -36759.826% |
| Altimmune, Inc. | 210.64 Million USD | -1968.553% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -460.138% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -3957.437% |
| Compugen Ltd. | 121.33 Million USD | -3491.079% |
| Peak Bio, Inc. | 2.59 Million USD | -167716.008% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -2428.449% |
| Benitec Biopharma Inc. | 52.21 Million USD | -8245.528% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -1174.561% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -12430.412% |
| Zura Bio Limited | 100.84 Million USD | -4220.776% |
| PolyPid Ltd. | 15.37 Million USD | -28245.043% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -3552.734% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -12430.412% |
| Instil Bio, Inc. | 325.63 Million USD | -1238.083% |
| argenx SE | 4.54 Billion USD | 4.078% |
| Immunome, Inc. | 148.54 Million USD | -2833.351% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -2677.498% |
| Verona Pharma plc | 308.12 Million USD | -1314.106% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -4910.637% |
| Shattuck Labs, Inc. | 159.56 Million USD | -2630.691% |
| CervoMed Inc. | 9.97 Million USD | -43592.061% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -2212.052% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -38161.328% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -2328.695% |
| Moolec Science SA | 24.05 Million USD | -18016.285% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -71125.407% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -2419.422% |
| AnaptysBio, Inc. | 452.38 Million USD | -863.153% |
| Design Therapeutics, Inc. | 289.64 Million USD | -1404.335% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -5883.11% |
| NeurAxis, Inc. | 509.49 Thousand USD | -855094.721% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -80320.819% |
| Lumos Pharma, Inc. | 40.63 Million USD | -10621.984% |
| Achilles Therapeutics plc | 161.45 Million USD | -2598.692% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -4910.637% |
| 180 Life Sciences Corp. | 5.25 Million USD | -82744.755% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -6086.762% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -50798.242% |
| Nutriband Inc. | 7.51 Million USD | -57863.426% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -1610.813% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -2086.241% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -5617.21% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -7423.31% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -727.515% |
| Palisade Bio, Inc. | 14.05 Million USD | -30907.686% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -1971.947% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -198.497% |
| Neurogene Inc. | 222.57 Million USD | -1857.65% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -573.841% |
| AEON Biopharma, Inc. | 6.84 Million USD | -63555.223% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -861.778% |
| Sesen Bio, Inc. | 189.17 Million USD | -2203.276% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -1502.695% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -31676.847% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -458.364% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -1531.947% |
| Athira Pharma, Inc. | 160.24 Million USD | -2619.086% |
| Vaccinex, Inc. | 3.63 Million USD | -119900.0% |
| HCW Biologics Inc. | 28.51 Million USD | -15181.097% |
| XOMA Corporation | 234.3 Million USD | -1759.659% |
| Nektar Therapeutics | 398.03 Million USD | -994.683% |
| Arvinas, Inc. | 1.3 Billion USD | -233.987% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -25474.425% |
| Merus N.V. | 458.49 Million USD | -850.329% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -2032.057% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -2317.926% |
| Rezolute, Inc. | 132.73 Million USD | -3182.581% |
| Clene Inc. | 52.34 Million USD | -8224.64% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -29096.165% |
| BeyondSpring Inc. | 24.8 Million USD | -17463.689% |
| Synlogic, Inc. | 75.55 Million USD | -5667.306% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -36632.423% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -46431.397% |
| Peak Bio, Inc. | 2.59 Million USD | -167716.008% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -2392.207% |
| Krystal Biotech, Inc. | 818.35 Million USD | -432.434% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -1712.193% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -500.341% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -121705.649% |
| MannKind Corporation | 475.19 Million USD | -816.923% |
| Ikena Oncology, Inc. | 192.09 Million USD | -2168.288% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -32479.632% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -3638.834% |
| Gossamer Bio, Inc. | 311.91 Million USD | -1296.915% |
| CohBar, Inc. | 16.36 Million USD | -26524.029% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -12291.434% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -59465.277% |
| Legend Biotech Corporation | 1.84 Billion USD | -135.702% |
| Mural Oncology plc | 301.74 Million USD | -1344.001% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -13858.674% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -76605.798% |
| Disc Medicine, Inc. | 367.99 Million USD | -1084.035% |
| Champions Oncology, Inc. | 26.13 Million USD | -16573.81% |
| REGENXBIO Inc. | 573.97 Million USD | -659.134% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -160795.984% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -2722.277% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -35982.739% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -1181.398% |
| Vaxart, Inc. | 91.83 Million USD | -4644.855% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -7173.652% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -2837.565% |
| Cellectis S.A. | 334.27 Million USD | -1203.497% |
| Longeveron Inc. | 12.17 Million USD | -35679.274% |
| Repare Therapeutics Inc. | 253.9 Million USD | -1616.102% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | -33.469% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -2069.413% |
| Revolution Medicines, Inc. | 2.08 Billion USD | -108.619% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -268035.385% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -1468.969% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -2571.523% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -3040.46% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -16972.33% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 80.831% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -277.601% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -35577.88% |
| Veru Inc. | 50.59 Million USD | -8511.761% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -9465.122% |
| Cingulate Inc. | 3.49 Million USD | -124696.788% |
| Passage Bio, Inc. | 150.54 Million USD | -2794.284% |
| Context Therapeutics Inc. | 16.06 Million USD | -27026.14% |
| Exicure, Inc. | 11.58 Million USD | -37526.943% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -1058.682% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -2595.587% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -24838.187% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -1209.471% |
| Nuvalent, Inc. | 732.38 Million USD | -494.934% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -29056.698% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -4765.444% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -30603.967% |
| OmniAb, Inc. | 401.98 Million USD | -983.921% |
| Anew Medical, Inc. | 19.45 Million USD | -22295.202% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -16202.887% |
| Lipocine Inc. | 23 Million USD | -18843.465% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -3016.582% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -1325.949% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -5090.773% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -3484.993% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -54811.153% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -393.859% |
| Ocugen, Inc. | 64.54 Million USD | -6650.43% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -3398.607% |
| Q32 Bio Inc. | 306.11 Million USD | -1323.368% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -103445.627% |
| Alumis Inc. Common Stock | 89.61 Million USD | -4762.295% |
| Equillium, Inc. | 50.53 Million USD | -8522.996% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -5694.534% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -10456.889% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -256077.342% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -16568.069% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -6661.534% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -116805.498% |
| Dominari Holdings Inc. | 57.55 Million USD | -7470.103% |
| Edesa Biotech, Inc. | 8.89 Million USD | -48909.964% |
| vTv Therapeutics Inc. | 11.01 Million USD | -39446.197% |
| Bio-Techne Corporation | 2.81 Billion USD | -54.885% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -364.957% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -436.966% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -1469.229% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -10348.42% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -552.678% |
| Nkarta, Inc. | 378.88 Million USD | -1050.006% |
| BioCardia, Inc. | 2.98 Million USD | -145772.112% |
| Iterum Therapeutics plc | 26.25 Million USD | -16493.168% |